Beam Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Beam Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $-1.11 | $-1.14 | 2.63 % |
Mar 2024 | 2024-05-07 | $-1.21 | $-1.42 | 14.8 % |
Dec 2023 | 2024-02-27 | $1.73 | $-1.01 | 271.3 % |
Sep 2023 | 2023-11-08 | $-1.22 | $-1.34 | 8.96 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $11.77M | $13.73M | -14.3 % |
Mar 2024 | 2024-05-07 | $7.41M | $16.97M | -56.3 % |
Dec 2023 | 2024-02-27 | $316.19M | $18.67M | 1593.6 % |
Sep 2023 | 2023-11-08 | $17.19M | $17.49M | -1.70 % |
Beam Therapeutics (BEAM) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $-1.11, which beat the estimate of $-1.14.
The Actual Revenue was $11.8M, which missed the estimate of $13.7M.
Browse earnings estimates, EPS, and revenue on all stocks.